We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-17.4%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.13B
AUM Growth
-$27.7M
Cap. Flow
+$215M
Cap. Flow %
18.92%
Top 10 Hldgs %
6.33%
Holding
1,227
New
318
Increased
332
Reduced
244
Closed
300

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$6.3M
2
HON icon
Honeywell
HON
+$6.1M
3
FICO icon
Fair Isaac
FICO
+$5.7M
4
USFD icon
US Foods
USFD
+$5.48M
5
BC icon
Brunswick
BC
+$5.2M

Top Sells

Rank Stock Value
1
ARCH
Arch Resources, Inc.
ARCH
+$6.65M
2
QLYS icon
Qualys
QLYS
+$6.64M
3
EOG icon
EOG Resources
EOG
+$5.88M
4
SPGI icon
S&P Global
SPGI
+$5.29M
5
MSCI icon
MSCI
MSCI
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 18.41%
3 Industrials 13.29%
4 Consumer Discretionary 11.36%
5 Financials 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRA icon
951
Atara Biotherapeutics
ATRA
$69.5M
-1,481
Closed -$344K
AUPH icon
952
Aurinia Pharmaceuticals
AUPH
$1.96B
-69,917
Closed -$866K
AVD icon
953
American Vanguard Corp
AVD
$75.2M
-22,577
Closed -$459K
AVIR icon
954
Atea Pharmaceuticals
AVIR
$386M
-224,660
Closed -$1.62M
AWI icon
955
Armstrong World Industries
AWI
$7.05B
-3,200
Closed -$288K
AWR icon
956
American States Water
AWR
$3.37B
-6,054
Closed -$539K
AXGN icon
957
Axogen
AXGN
$2.19B
-18,337
Closed -$146K
AXS icon
958
AXIS Capital
AXS
$8.63B
-19,784
Closed -$1.2M
BBIO icon
959
BridgeBio Pharma
BBIO
$16.5B
-55,433
Closed -$563K
BDTX icon
960
Black Diamond Therapeutics
BDTX
$99.1M
-66,168
Closed -$183K
BEN icon
961
Franklin Resources
BEN
$17.3B
-23,319
Closed -$651K
BHF icon
962
Brighthouse Financial
BHF
$3.63B
-6,874
Closed -$355K
BIIB icon
963
Biogen
BIIB
$29.5B
-6,544
Closed -$1.38M
BMRN icon
964
BioMarin Pharmaceuticals
BMRN
$11.6B
-6,888
Closed -$531K
BN icon
965
Brookfield
BN
$103B
-11,024
Closed -$336K
BNED icon
966
Barnes & Noble Education
BNED
$445M
-238
Closed -$85K
BOLT icon
967
Bolt Biotherapeutics
BOLT
$7.64M
-611
Closed -$33K
BOX icon
968
Box
BOX
$4.18B
-35,921
Closed -$1.04M
BPMC
969
DELISTED
Blueprint Medicines
BPMC
-3,874
Closed -$247K
BTU icon
970
Peabody Energy
BTU
$2.81B
-11,900
Closed -$292K
BBBY
971
Bed Bath & Beyond
BBBY
$512M
-13,351
Closed -$534K
CALX icon
972
Calix
CALX
$2.32B
-23,256
Closed -$998K
CARG icon
973
CarGurus
CARG
$3.15B
-12,907
Closed -$548K
CCRN
974
DELISTED
Cross Country Healthcare
CCRN
-23,810
Closed -$516K
CGC
975
Canopy Growth
CGC
$390M
-15,073
Closed -$1.14M

Similar funds

PDT Partners's Q2 2022 Portfolio in Review

As of Q2 2022, PDT Partners held 1,227 positions worth $1.13B, down 2.4% from $1.16B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

PDT Partners deployed $215M of net new capital in Q2 2022, opening 318 new positions and adding to 332 existing holdings. Its largest new stake was Honeywell: 33,974 shares worth $5.57M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Arch Resources, Inc., an estimated $6.65M trimmed.

  • PDT Partners's largest Q2 2022 buy was Honeywell: 33,974 shares worth $5.57M.
  • PDT Partners added most to Carvana in Q2 2022, an estimated $6.3M increase.
  • PDT Partners's biggest Q2 2022 reduction was Arch Resources, Inc., cutting an estimated $6.65M.
  • PDT Partners fully exited Qualys in Q2 2022, selling an estimated $6.64M.
  • PDT Partners's ten largest holdings make up 6.3% of its $1.13B portfolio in Q2 2022.
  • PDT Partners opened 318 new positions and closed 300 in Q2 2022.
  • PDT Partners's portfolio value fell 2.4% quarter-over-quarter to $1.13B.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.